Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (249936), PE/Atto594, Novus Biologicals™
SDP

Catalog No. NB313991 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB313991 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB313991 Supplier Novus Biologicals Supplier No. FAB1898PEATT594
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

CD229/SLAMF3/Lymphocyte Antigen 9 Monoclonal antibody specifically detects CD229/SLAMF3/Lymphocyte Antigen 9 in Human samples. It is validated for Flow Cytometry

Specifications

Antigen CD229/SLAMF3/Lymphocyte Antigen 9
Applications Flow Cytometry
Classification Monoclonal
Clone 249936
Conjugate PE/ATTO 594
Dilution Flow Cytometry
Formulation PBS
Gene Alias CD229, CD229 antigen, cell-surface molecule Ly-9, hly9, lymphocyte antigen 9Cell surface molecule Ly-9, mLY9, SLAMF3, T-lymphocyte surface antigen Ly-9
Host Species Mouse
Immunogen Mouse myeloma cell line NS0-derived recombinant human CD229/SLAMF3, Lys48-Lys454, Accession # Q9HBG7
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Gene ID (Entrez) 4063
Target Species Human
Content And Storage Store at 4C in the dark. Do not freeze.
Form Purified
Isotype IgG2a
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.